Is There a Treatment for COVID-19?

Yes! If you’ve tested positive for COVID-19 and your symptoms began in the past 10 days, OR if you're not fully vaccinated or are immunocompromised and you've been exposed to COVID-19, you may be eligible for a free treatment at the Fitness One building on DCH’s Northport Medical Center campus.

The Power of Antibodies

Monoclonal antibodies, or mAbs, are man-made proteins that help your body fight off the virus that causes COVID-19. In fact, just one mAb treatment can help keep you from getting sicker and going to the hospital.

DCH Health System , Alabama Department of Public Health, and HHS partner to expand access to monoclonal antibody therapy to COVID-19 patients

DCH Health System, in partnership with the Alabama Department of Public Health and the U.S. Department of Health and Human Services (HHS), announced it has expanded access to COVID-19 monoclonal antibody (mAb) therapies at Northport Medical Center in the Fitness One building. For people who are at high risk for developing severe COVID-19 illness and have tested positive for the COVID-19 virus or are unvaccinated and have been exposed to someone who has tested positive, this promising mAb treatment has been shown to help prevent progression of the disease that might otherwise require hospitalization.

With the rapid spread of the Delta variant and a major surge in COVID-19 case rates, DCH Health System will expand access to the mAb infusion treatment for eligible patients at the Northport Medical Center in the Fitness One building located at 2700 Hospital Drive in Northport, AL. With the expansion, DCH Health System will be able to increase the number of patients treated with mAbs from 100 per week to 240 per week. Patients can receive the mAb treatment Monday through Friday from 7 a.m. to 5 p.m. and Saturdays from 8 a.m. to 12 p.m.

To confirm eligibility for the treatment and book an appointment, patients should contact their primary health care provider or call 1-833-TREAT-COVID (1-833-873-2826). For more information about monoclonal antibodies visit www.crushcovid.com.

Read the full release here.

ARE YOU ELIGIBLE FOR mAbs?

You may be eligible if you are 12 years of age or older (and at least 88 pounds), are at high risk** of developing severe COVID-19 symptoms, and meet one of the following criteria:

• You’ve recently tested positive for COVID-19

• You’ve not been fully vaccinated or are immunocompromised and you’ve either had recent exposure to COVID-19 or there’s a high likelihood you’ve been exposed because of an infection in an institutional setting, such as a nursing home or penitentiary.

Not sure if you qualify?

Contact your healthcare provider to see if you’re eligible for mAbs.

**High risk includes any of the following characteristics or conditions:

• 65 years of age or older
• Overweight (body mass index over 25)
• Pregnancy
• Chronic kidney disease
• Diabetes (Type 1 and Type 2)
• Weakened immune system
• Currently receiving immunosuppressive treatment
• Cardiovascular disease/hypertension
• Chronic lung disease
• Sickle cell disease
• Neurodevelopmental disorders
• Medical-related technological dependence

Other medical conditions or factors such as race or ethnicity may also place individual patients at high risk for progressing to severe COVID-19.